Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMI-001 for the Prophylaxis of Veisalgia
NCT02737397Phase 2Completed
- Sponsor
- Sen-Jam Pharmaceutical
- Start
- Mar 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of SJP-001 in alcohol hangover, sponsored by Sen-Jam Pharmaceutical. Started Mar 2016; status: completed.
02
Drugs
SJP-001
03
Conditions
alcohol hangover
Beyond the preview
Go deeper on NCT02737397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737397.